Preclinical radioimmunotargeting of folate receptor alpha using the monoclonal antibody conjugate DOTA–MORAb-003
- 30 April 2008
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 35 (3), 343-351
- https://doi.org/10.1016/j.nucmedbio.2007.12.008
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- The role of folate receptor α in cancer development, progression and treatment: Cause, consequence or innocent bystander?International Journal of Cancer, 2006
- Ligand Binding and Kinetics of Folate Receptor Recycling in Vivo: Impact on Receptor-Mediated Drug DeliveryMolecular Pharmacology, 2004
- Cellular and humoral responses after multiple injections of unconjugated chimeric monoclonal antibody MOv18 in ovarian cancer patients: a pilot studyZeitschrift für Krebsforschung und Klinische Onkologie, 2002
- Biokinetics of the Monoclonal Antibodies MOv 18, OV 185 and OV 197 Labelled with125I According to the m-MeATE Method or the Iodogen Method in Nude Mice with Ovarian Cancer XenograftsActa Oncologica, 1999
- Growth of ovarian‐carcinoma cell lines at physiological folate concentration: Effect on folate‐binding protein expression in vitro and in vivoInternational Journal of Cancer, 1995
- A Facile, Water-Soluble Method for Modification of Proteins with DOTA. Use of Elevated Temperature and Optimized pH To Achieve High Specific Activity and High Chelate Stability in Radiolabeled ImmunoconjugatesBioconjugate Chemistry, 1994
- Preclinical pharmacokinetics and localization studies of the radioiodinated anti-ovarian carcinoma MAb MOv18International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1991
- [65] Determination of the true immunoreactive fraction of monoclonal antibodies after radiolabelingMethods in Enzymology, 1986
- Cell surface antigens of human trophoblast and choriocarcinoma defined by monoclonal antibodiesInternational Journal of Cancer, 1985
- Surface-specific iodination of membrane proteins of viruses and eucaryotic cells using 1,3,4,6-tetrachloro-3α,6α-diphenylglycolurilBiochemistry, 1978